1093956-75-2

Upstream product

• 1093956-66-1 1-[(2E)-3-(3,5-difluorophenyl)-2-propenoyl]-4-(2-oxiranyl)piperidine 
• 1093956-65-0 1-[(2E)-3-(3,5-difluorophenyl)-2-propenoyl]-4-piperidinecarbaldehyde 
• 1093956-64-9 {1-[(2E)-3-(3,5-difluorophenyl)-2-propenoyl]-4-piperidinyl}methanol 
• 84315-23-1 (trans)-3-(3,5-difluorophenyl)acrylic acid 
• 6457-49-4 4-piperidinemethanol 

Downstream Products

• 1150315-62-0 (1S)-1-{1-[(2E)-3-(3,5-difluorophenyl)-2-propenoyl]-4-piperidinyl}-2-(6-methyl-1'H-spiro[1-benzofuran-3,4'-piperidin]-1'-yl)ethanol 
• 1150315-63-1 (3R,3'R)-6-chloro-1'-((2S)-2-{1-[(2E)-3-(3,5-difluorophenyl)-2-propenoyl]-4-piperidinyl}-2-hydroxyethyl)spiro[1-benzofuran-3,4'-piperidin]-3'-ol 

Relevant academic research and scientific papers

SPIRODIHYDROBENZOFURANS AS MODULATORS OF CHEMOKINE RECEPTORS

The present invention relates to a compound of the following formula: or a pharmaceutically acceptable salt thereof, wherein R1 -R4, R8, R9, Y, m, n, and p are defined. Compounds and compositions of the present

SPIROINDENES AND SPIROINDANES AS MODULATORS OF CHEMOKINE RECEPTORS

The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof; where R1-R5, Y, m, n, and p are defined herein. Compounds and compositions of the present invention are useful the treatment of atherosclerosis.